Preclinical studies show thattumor-induced inhibition of DC differentiation is mediated by tumor-derivedsoluble factors such as IL-10, IL-6, M-CSF, prostaglandins, and vascular endothelialgrowth factor (VEGF) [7–11]. The gene discussed is IL6; the disease is neoplasm.